Show results for
Refine by
Drug Designation Software In Europe
5 software items found
by:Cresset Group based inCambridgeshire, UNITED KINGDOM
A single platform for ligand-based and structure-based drug design that enables research chemists to discover novel small molecules more efficiently and ...
by:Iktos based inParis, FRANCE
Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization ...
by:MasterControl, Inc based inSalt Lake City, UTAH (USA)
Small Medical Device Companies Can Now Manage and Automate their Design Control Process to Ensure Compliance with 21 CFR Part 820 with the Help of MasterControl's Design Control Software Systems at a Low Monthly Cost. Each manufactured medical device must be supported by appropriate documentation which demonstrates that its development followed the Food and ...
by:Molecular Health GmbH based inHeidelberg, GERMANY
Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities eliminate the uncertainties that limit drug development but are data-intensive and experimentally inaccessible. Molecular Health Dataome Technology offers powerful solutions to ...
by:Genuity Science based inBoston, MASSACHUSETTS (USA)
We are developing novel causal artificial intelligence and machine learning (AI/ML) and unconventional computing strategies to better understand human biology – and then apply these to deliver better medicine and improve health for people around the ...